Hepatic Carcinoma
29
2
3
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.4%
1 terminated out of 29 trials
92.9%
+6.4% vs benchmark
14%
4 trials in Phase 3/4
15%
2 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (29)
Development of a Neuronal Microscope
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Prehabilitation and Posttransplant Training Program in Liver Transplantation
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.
Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension
Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy
to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma
A Study to Evaluate Vaccines Against COVID-19 in the Real World
Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function
Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder
ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma
A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs
Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
Arterial Base Fluorescence Segmental Positive Staining